Difference between revisions of "Team:Tianjin/Demonstrate"

Line 224: Line 224:
 
   <h4>Obtaining the chassis </h4>
 
   <h4>Obtaining the chassis </h4>
 
<hr>
 
<hr>
   <p>Aiming to achieve MTS for environmental use, it is essential to make sure that when the MAT locus has DSB (double strands break) cleaved by HO, our type-a (<i>MATa</i>) yeast can only become type-α (<i>MATα</i>). Therefore, we used a <i>Ura-tag</i> to replace the<i> HMRa</i> domain in <i>chromosome Ⅲ</i>. In this way the <i>HMRa</i> will no longer be the donor for the homologous recombination in the repairing process for MAT cleavage. Since the change of mating type may appear successively, there is a great possibility that the same type haploid mate with each other. To avoid the existence of meaningless mating, we built an vector to express <i>MATα</i> genes to produce <i>a1-α2 stable corepressor</i> so that the haploid will regard itself as a diploid and prevent mating unless the <i>MATa</i> locus changes to the other one. After selection, by homologous recombination, we deleted the <i>Ura-tag</i> for further usage. We selected the target colonies (<i>SynⅩ-dUra</i>) via <i>5-FOA</i> plates. </p>
+
   <p>Aiming to achieve MTS for environmental use, it is essential to make sure that when the <i>MAT</i> locus has DSB (double strands break) cleaved by <i>HO</i>, our type-a (<i>MATa</i>) yeast can only become type-α (<i>MATα</i>). Therefore, we used a <i>Ura-tag</i> to replace the<i> HMRa</i> domain in <i>chromosome Ⅲ</i>. In this way the <i>HMRa</i> will no longer be the donor for the homologous recombination in the repairing process for MAT cleavage. Since the change of mating type may appear successively, there is a great possibility that the same type haploid mate with each other. To avoid the existence of meaningless mating, we built an vector to express <i>MATα</i> genes to produce <i>a1-α2 stable corepressor</i> so that the haploid will regard itself as a diploid and prevent mating unless the <i>MATa</i> locus changes to the other one. After selection, by homologous recombination, we deleted the <i>Ura-tag</i> for further usage. We selected the target colonies (<i>SynⅩ-dUra</i>) via <i>5-FOA</i> plates. </p>
 
   <img src="https://static.igem.org/mediawiki/2017/7/7e/Tianjin-ho-result-1.jpeg">
 
   <img src="https://static.igem.org/mediawiki/2017/7/7e/Tianjin-ho-result-1.jpeg">
 
   <p>Fig.1.We successfully acquired the target yeasts as our chassis (<i>SynⅩ-dUra</i>).</p>
 
   <p>Fig.1.We successfully acquired the target yeasts as our chassis (<i>SynⅩ-dUra</i>).</p>
Line 231: Line 231:
 
   <p>In this pathway, we chose <i>Gal1</i> as our inducible promoter for the expression of <i>HO</i> gene, <i>CYC1</i> as the terminator, and <i>PRS416</i>(with <i>Ura-tag</i>) as our vector. As for segments ligation, we designed the cutting sites for <i>Bsa1</i> enzyme in each part, hoping to achieve seamless ligation of these three parts.</p>
 
   <p>In this pathway, we chose <i>Gal1</i> as our inducible promoter for the expression of <i>HO</i> gene, <i>CYC1</i> as the terminator, and <i>PRS416</i>(with <i>Ura-tag</i>) as our vector. As for segments ligation, we designed the cutting sites for <i>Bsa1</i> enzyme in each part, hoping to achieve seamless ligation of these three parts.</p>
 
<p>We adopted the PCR method to amplify the <i>Gal1-part</i> and <i>CYC1-part</i> from a <i>Gal1-Vika</i> plasmid we had used in our former lab work with specially designed primers for this procedure. After PCR, the <i>Gal1</i> has the cutting sites for <i>SalⅠ</i>and <i>BsaⅠ</i>on both ends, and <i>CYC1</i> has that for <i>BsaⅠ</i>and <i>BamhⅠ</i>on both ends. Meanwhile, the <i>HO</i> gene was obtained by gene synthesis, flanked by specific hangtags for <i>BsaⅠ</i>in order to be cohesive with <i>Gal1</i> (upstream) and <i>CYC1</i> (downstream). Thus, we have built our composite part (<i>GHC</i>).</p>
 
<p>We adopted the PCR method to amplify the <i>Gal1-part</i> and <i>CYC1-part</i> from a <i>Gal1-Vika</i> plasmid we had used in our former lab work with specially designed primers for this procedure. After PCR, the <i>Gal1</i> has the cutting sites for <i>SalⅠ</i>and <i>BsaⅠ</i>on both ends, and <i>CYC1</i> has that for <i>BsaⅠ</i>and <i>BamhⅠ</i>on both ends. Meanwhile, the <i>HO</i> gene was obtained by gene synthesis, flanked by specific hangtags for <i>BsaⅠ</i>in order to be cohesive with <i>Gal1</i> (upstream) and <i>CYC1</i> (downstream). Thus, we have built our composite part (<i>GHC</i>).</p>
<p>After the ligation of <i>GHC</i> and <i>PRS416</i> Plasmid (<i>GHC-416</i>), we transformed the E. coli for the augment of our new plasmid—— <i>GHC-416</i>. We examined the transformation result by PCR method to amplify the <i>HO</i> gene in the E. coli which we randomly selected in the plate.   
+
<p>After the ligation of<b><i>GHC</i></b> and <i>PRS416</i> Plasmid (<b><i>GHC-416</i></b>), we transformed the E. coli for the augment of our new plasmid——<b><i>GHC-416</i></b>. We examined the transformation result by PCR method to amplify the <i>HO</i> gene in the E. coli which we randomly selected in the plate.   
 
</p>
 
</p>
 
   <img src="https://static.igem.org/mediawiki/2017/b/b9/Tianjin-ho-result-666.jpeg">
 
   <img src="https://static.igem.org/mediawiki/2017/b/b9/Tianjin-ho-result-666.jpeg">
 
<p>Fig.2.The results of PCR of #6, #7, #16, #20, #27, #36, #37, #55 colonies. <i>HO</i> gene (length of 1770bp). As we can see, <i>HO</i> gene in all 8 colonies has been amplified, which indicated that we succeeded in constructing the device for <i>HO</i> gene expression.</p>
 
<p>Fig.2.The results of PCR of #6, #7, #16, #20, #27, #36, #37, #55 colonies. <i>HO</i> gene (length of 1770bp). As we can see, <i>HO</i> gene in all 8 colonies has been amplified, which indicated that we succeeded in constructing the device for <i>HO</i> gene expression.</p>
   <h4>The result of mating type switching(MTS)</h4>
+
   <h4>The result of mating type switching(<b>MTS</b>)</h4>
 
<hr>
 
<hr>
   <p>We transformed the chassis yeasts for the new device——<i>GHC-416</i>, the new yeasts we selected in the <i>Sc-Ura</i> plate is named as <i>SynⅩ-dUra-416</i>.</p>
+
   <p>We transformed the chassis yeasts for the new device——<b><i>GHC-416</i></b>, the new yeasts we selected in the <i>Sc-Ura</i> plate is named as <b><i>SynⅩ-dUra-416</i></b>.</p>
  
<p>In this section, we only got to test the Gal System due to time limit. And we figured that the result for Gal System is adequately enough to represent the feasibility of our designed strategy for MTS.  
+
<p>In this section, we only got to test the <i>Gal</i> System due to time limit. And we figured that the result for <i>Gal</i> System is adequately enough to represent the feasibility of our designed strategy for <b>MTS</b>.  
 
</p>
 
</p>
 
   <img>
 
   <img>
 
   <p>The whole test process can be divided into three steps.</p>
 
   <p>The whole test process can be divided into three steps.</p>
 
     <h5> 1) Step one</h5>
 
     <h5> 1) Step one</h5>
       <p> Activate the Gal1 promoter. After that, the expression of HO gene in the SynⅩ-dUra-416 can be initiated.</p>
+
       <p> Activate the <i>Gal1</i> promoter. After that, the expression of HO gene in the <b><i>SynⅩ-dUra-416</i></b> can be initiated.</p>
 
     <h5>2)  Step two</h5>
 
     <h5>2)  Step two</h5>
 
     <p> Cultivate two groups of yeasts together. (one is SynⅩ-dUra-416, the other is normal BY4741 MATa) If the MTS has been accomplished (SynⅩ-dUra-416 can become MATα), the two groups of haploids can mate with each other and become diploids. </p>
 
     <p> Cultivate two groups of yeasts together. (one is SynⅩ-dUra-416, the other is normal BY4741 MATa) If the MTS has been accomplished (SynⅩ-dUra-416 can become MATα), the two groups of haploids can mate with each other and become diploids. </p>

Revision as of 11:34, 27 October 2017

/* OVERRIDE IGEM SETTINGS */

Demonstrate